LENSAR, Inc. (LNSR) Reports Q3 Loss of $0.64

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to LENSAR, Inc. (LNSR) Reports Q3 Loss of $0.64

LENSAR Reports Third Quarter 2020 Financial Results and Provides Business Update

November 9, 2020 4:01 PM EST

Procedure Numbers Consistent with 2019 Levels

Cash and Cash Equivalents of $42.7 Million as of September 30, 2020

ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (NASDAQ: LNSR) (LENSAR or the Company), a global medical technology company focused on femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the third quarter ended September 30, 2020 and provided an update on key strategic and operational initiatives. The distribution of LENSAR common stock to stockholders of PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) took... More